Mednet Logo

Would you consider the use of rilonacept to treat refractory pericarditis in lupus?

Community PollStarted

What medications do you utilize for management of pericarditis in the setting of rheumatic disease?

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)
Answered on

Firstly, I have not had a truly refractory lupus pericarditis patient in a very long time. This would mean not responding to, or having intolerances to, antimalarials, MTX, mycophenolate, azathioprine, tacrolimus, IVIG, steroids, colchicine, NSAIDs, rituximab, belimumab, IVIG, and now (thank goodnes...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Cardiology · John Hopkins Medicine
Answered on · Updated on

I would. There is no data that I am aware of, but I would. I explain why below.

Patients with autoimmune diseases were excluded from the clinical trial that led to the approval of Riloancept and this class of patients is also excluded from the recurrent pericarditis registry sponsored by Kiniksa pha...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Rheumatology · University of Michigan
Answered on

In my opinion, a better first step (beyond colchicine) to use Il1 pathway inhibition for refractory lupus pericarditis is a trial of Anakinra. This compound has been effective against idiopathic pericarditis in a good RCT. Its shorter half-life and lower initial cost than rilonacept make a short ini...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Cardiology · University of Nebraska Medical Center
Answered on

We just need to be aware that the pathophysiology of idiopathic recurrent pericarditis is different than of pericarditis secondary to an autoimmune process such as lupus as it is mediated by the adaptive immune system and Type 1 Interferon. Since with the former is driven by an ongoing cycle of IL-1...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Beth Israel Deaconess Medical Center
Answered on

I agree. I would use IL-1 inhibitors in cases where all other conventional immune suppressives or biologics are not helpful in controlling the disease and allow for steroid tapering.

Join for free or sign in to see the full answer